Audio-Visual Neuromodulation for Neuropathic Pain
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Massachusetts Policy 255 alerts
Get alerted when Policy 255 changes without checking for updates manually.
Monitor payer policy activity
This policy governs FDA-authorized prescription audiovisual digital therapeutics using dedicated wearable hardware and software to treat neuropathic pain, including chronic lower back pain. The service is considered investigational for commercial and Medicare Blue members and is not covered where the policy-specific outpatient determination applies.
A new medical policy was created stating that FDA-authorized prescription audiovisual digital therapeutics for neuropathic pain are investigational.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.